{"ABBV": {"Ticker": "ABBV", "Company": "AbbVie", "Sector": "Health Care", "Updated": "2023-02-22", "Rating": [{"Date": "2023-02-22", "Rating": "Downgrade", "Organization": "Wolfe Research", "Rating_Change": "Outperform to Peer Perform", "Target_Change": ""}, {"Date": "2023-02-10", "Rating": "Upgrade", "Organization": "SVB Securities", "Rating_Change": "Underperform to Market Perform", "Target_Change": "$135 to $153"}], "Score": 0.0, "Cumulative_Rating": "Neutral", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "C", "Analists": ["Wolfe Research", "SVB Securities"], "Price_Target": 153.0}, "AIG": {"Ticker": "AIG", "Company": "American International Group", "Sector": "Financials", "Updated": "2023-02-22", "Rating": [{"Date": "2023-02-22", "Rating": "Downgrade", "Organization": "Atlantic Equities", "Rating_Change": "Overweight to Neutral", "Target_Change": "$70 to $65"}, {"Date": "2023-01-20", "Rating": "Initiated", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform", "Target_Change": "$64"}], "Score": -1.0, "Cumulative_Rating": "Underperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "D", "Analists": ["Atlantic Equities", "BMO Capital Markets"], "Price_Target": 64.5}, "HD": {"Ticker": "HD", "Company": "Home Depot", "Sector": "Consumer Discretionary", "Updated": "2023-02-22", "Rating": [{"Date": "2023-02-22", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Buy", "Target_Change": "$350 to $340"}, {"Date": "2023-02-22", "Rating": "Reiterated", "Organization": "Robert W. Baird", "Rating_Change": "Outperform", "Target_Change": "$360 to $340"}, {"Date": "2023-02-22", "Rating": "Reiterated", "Organization": "Morgan Stanley", "Rating_Change": "Overweight", "Target_Change": "$360 to $340"}, {"Date": "2023-02-22", "Rating": "Reiterated", "Organization": "Loop Capital", "Rating_Change": "Hold", "Target_Change": "$310 to $300"}, {"Date": "2023-02-22", "Rating": "Reiterated", "Organization": "Evercore ISI", "Rating_Change": "Outperform", "Target_Change": "$370 to $340"}, {"Date": "2023-02-22", "Rating": "Reiterated", "Organization": "DA Davidson", "Rating_Change": "Neutral", "Target_Change": "$334 to $306"}, {"Date": "2023-02-22", "Rating": "Reiterated", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$335 to $320"}, {"Date": "2023-02-22", "Rating": "Reiterated", "Organization": "Cowen", "Rating_Change": "Outperform", "Target_Change": "$379 to $360"}, {"Date": "2023-02-22", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$340 to $332"}, {"Date": "2023-02-22", "Rating": "Reiterated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$323 to $310"}, {"Date": "2023-02-08", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$323"}, {"Date": "2022-12-20", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Neutral", "Target_Change": "$390 to $335"}, {"Date": "2022-12-06", "Rating": "Initiated", "Organization": "Bernstein", "Rating_Change": "Mkt Perform", "Target_Change": "$337"}], "Score": 0.92, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 13, "Period": "180 days", "Letter_Rating": "B", "Analists": ["Loop Capital", "UBS", "Barclays", "Credit Suisse", "Evercore ISI", "Morgan Stanley", "Bernstein", "Citigroup", "Robert W. Baird", "DA Davidson", "Cowen"], "Price_Target": 329.46}, "MRK": {"Ticker": "MRK", "Company": "Merck & Co.", "Sector": "Health Care", "Updated": "2023-02-22", "Rating": [{"Date": "2023-02-22", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Outperform", "Target_Change": "$127"}, {"Date": "2023-01-04", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Buy", "Target_Change": "$110 to $130"}], "Score": 2.0, "Cumulative_Rating": "Significant Outperform", "Number_of_Analysts": 2, "Period": "180 days", "Letter_Rating": "A", "Analists": ["BofA Securities", "Wolfe Research"], "Price_Target": 128.5}, "OXY": {"Ticker": "OXY", "Company": "Occidental Petroleum", "Sector": "Energy", "Updated": "2023-02-22", "Rating": [{"Date": "2023-02-22", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "In-line to Underperform", "Target_Change": "$74 to $60"}, {"Date": "2023-02-14", "Rating": "Upgrade", "Organization": "Goldman", "Rating_Change": "Neutral to Buy", "Target_Change": "$81"}, {"Date": "2023-01-10", "Rating": "Resumed", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": "$81 to $82"}, {"Date": "2023-01-06", "Rating": "Upgrade", "Organization": "BofA Securities", "Rating_Change": "Neutral to Buy", "Target_Change": "$80"}], "Score": 1.25, "Cumulative_Rating": "Outperform", "Number_of_Analysts": 4, "Period": "180 days", "Letter_Rating": "B", "Analists": ["BofA Securities", "Goldman", "Mizuho", "Evercore ISI"], "Price_Target": 75.75}}